Is Coretag Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Coretag Inc (COTI) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Coretag Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Coretag Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Coretag Inc?

Muslim investors may consider investing in Coretag Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Coretag Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Coretag Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Coretag Inc updated?

The Shariah compliance status of Coretag Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Coretag Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Coretag Inc?

You can check the latest Shariah compliance status of Coretag Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Coretag Inc. Stock Analysis COTI

United States N/A Nano Cap

Coretag, Inc. engages in the business of marketing and distribution of ladies’ fashion handbags. The company is headquartered in Liverpool, New York and currently employs 0 full-time employees. The company went IPO on 2015-11-17. The firm developed NTPT as a result of the discovery of a group of cyanine dyes which have selective targeting properties for intracellular proteins. These proteins become available for binding only when the cell membrane loses its integrity, which occurs once a cell has become necrotic. The firm has developed a portfolio of products that address high unmet needs in oncology. The firm develops targeted radiotherapy with 177Lu (lutetium) and 121Pb (lead) for the treatment of rapidly growing tumors and metastasis. The company also develops targeted diagnostics with 89Zr (zirconium) and 111In (indium) for detecting and quantifying necrotic tissue in the human body.

Key Statistics of Coretag Inc (COTI)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.01$0.01

Today's Open

$0.01

Volume

100.00

P/E Ratio (TTM)

Market Cap

942.00

Avg. Volume